Boston Scientific logo

BSX PR A - Boston Scientific News Story

$118.21 -1.5  -1.2%

Sector
Healthcare
Size
Large Cap
Market Cap £45.97bn
Enterprise Value £50.66bn
Revenue £8.15bn
Position in Universe th / 7149

BRIEF-Late-Breaking Trial Data At Tvt Demonstrate Sustained Safety And Performance Of Watchman Flx™ Left Atrial Appendage Closure Device

Wed 21st July, 2021 12:17pm
July 21 (Reuters) - Boston Scientific Corp  BSX.N :
    * LATE-BREAKING TRIAL DATA AT TVT DEMONSTRATE SUSTAINED
SAFETY AND
PERFORMANCE OF WATCHMAN FLX™ LEFT ATRIAL APPENDAGE CLOSURE
DEVICE

Source text for Eikon:  ID:nPnc5MFTka 
Further company coverage:  BSX.N 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.